Skip to content

Clinical trials

Phase 3 Sleep Apnea, Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Apnea, Obstructive Phase: Phase 3 Country / region: United States Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20044
20051
20061
20074
20081
20092
20102
20113
20122
20141
20153
20191
20221
20234
20241
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting4
Terminated3
Active, not recruiting2
Not yet recruiting1
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cephalon5
Eli Lilly and Company4
Apnimed3
Jazz Pharmaceuticals3
Novo Nordisk A/S3
Amgen2
Clayton Sleep Insititute2
Stanford University2
Apnex Medical, Inc.1
Cardiox Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Apnea, Obstructive39
Obesity10
Sleep Apnea Syndromes7
Disorders of Excessive Somnolence6
Overweight6
Narcolepsy5
Apnea2
Diabetes Mellitus, Type 22
Sleep Wake Disorders2
Cataplexy1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.